SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: margie who wrote (1267)12/31/1998 3:05:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 1722
 
Celebrex was approved today, but label still considers it a NSAID. Details in New Therapeutics section
(COX-2 Inhibitor page) at biocognizance.com
(This morning on CNBC COX-2 inhibitors were projected to be the drug story for 1999).